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The ~"t~n of lhe ~ ~ ~,"~__ s,p~a~e (iNOS) and the a=m¢~ 
am~ nine m~e (NOz) ~ may ~ m me pamegen~= 
of ~ hea~ ~(HF)  " n ~ w a = ~ m ~ ( p ~ )  
with seven) HF caused bY ~ ~ caR l~f f~y  (IDC) and =s- 
cheme d~ease tlsch) who undan=em heart ~ a~l  m Cmdm¢ dor~s. 
INO~ mRNA eJqpIRt~MsiOII W~S e~iCuatsd m 18fl alld fi~ltl ~l~l~lr,~uk~ ~ by 
RT, PCR "n~ ~ an~l r~m r~xlu~ m pm~ to be 8~7 I~ ~o~e- 
s~( l~g to the eDNA ba~ se¢~eme of human ~NOS. NO~ serum co.cm~ra- 
hen was meesumd by a It~mm~c lechnique./Ul pts were m NYHA class IV 
and (k)nem in class i. ~ n ~  f~r eml ( f~  ~eft 
~nnc~ar d ~  (EOO) and e je~ f ra~ (EF) were c ~  be~ 
~ t ~ , -  Flesuns me m the talge 
IOC Isch 0o,.o~ 
p~ 10 4 4 
Age iV) 55±5 58±2 56±4 
EF (%) 19 : 7 ;~; ~ 2 NO~ 
ED0 (rn~n! 79 ± 10 73 : 7 
,NOS t~m) 100% 20". 0% 
(rd~*nd) 25,3 1:475 56 : 3 40 ~: 2 5 
/n Cor~--/us~n. Pts tnttt HF (rue to IOC had I~gher mc~eftce of iNOS ex- 
~ zn car~ ~.~.~ue attcl hzg~=r plasma NO~. 
~ D D  Genolype of the Angiotensin Converting 
Enzyme Gene Is Associated W'dh a Greater 
Improve l l te l t l  o f  I .e lt  Ve f l ldcu l l r  Funct ion  in 
Patisms With idiopathic Oibted Cam'~,mjo~t~ 
Treated Wilh ACE Inhibilors 
D. Sku~ck'y, I. P, adevskt. G. Car~,  G. Notlo~, P. Samfl. Bata~ 
Hos~fat. Jottannesl~.,g. South/:.:ca 
The DD gePotype of the mser~h0n (IR}) ~ of the ang~o- 
ter~n converting enzyme (ACE) gene has been found to be assooated 
an increased mortality and an increased plasma ACE activity in patients (pts) 
with ddated cam'iomyopatl~ (DCMO). The effect of ACE-inhibilo:s on cardiac 
pedonnance in pts wdh DCMO and camjing edher the D, I 0¢ both alleles has 
not been determined. We followed pmspectevely 59 ~ ~ with DCMO for 
40 ± 10 months (mean age 57 ± 8 y~s, 61% males, radionuctide jec l~ 
fractmn (Rn EF) <40%). All pts were treated with digoxin, furosemide and 
Trandolapnl 4 mg dly. ACE gene distribution was: DD 35%. ID 46% and It 
19%. Baseline dincat characteristics were similar I ~  groups except for 
ejection fraction which was lower in the DD group (p = 0.001). Results of Rn 
EF at baseline and after 1 year el treatment with Trandotaprfl are sho~n in the 
table. 
Baseline 1 year % improvement 
DO (n = 21) 23 ± 5% 39 ± 14%" 67# 
lD/ll (n = 38) 29 ± 6% 38 ± 15%" 36 
• = p < 0.001 companng baseline and 1 year.# = p 004 between the DO and the ID/~I 
group. 
Conclusion: pts with DCMO and DD genotype of the ACE §ene have a 
signdicantly greater improvement in EF than the ID/II group when treated with 
Trandolapril. 
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myopathy (MM) i~tmm hewe ~0ar mu=cut~ ct~,  we 
A4~/~¢~ Nif~ MM I~l#~ntl and 9 8gt~, BMI amt lm~ malche¢l h~lltby 
~ were ~ (4~e • 4.7 vs 48.0.3~6y, 2S,e • 13 v 2~e ± 1.e 
~o m~'w were ~ (t~ep~ of r~e ~ line .~a~ venm~e~ (v 
E) and carom d~Ue I~oductmm (V COz ))~ 
Re~,~s: MM ipal~nts had a lower peak V O~ (15,6 ± 1,9 vs 32.4 ~42 
m l ~  p.~ 0.005) am~ooated with il hq]he~ V EN CO= SlOl~ (25.9 ± 1.6 
vs 37'2 P< 0.01 ). The mq~raloW exchange relK~ achieved at peak ~ 
were Ib~m~l~ ( 121 ~ 0.04 vs 125 ± O07 P= NS) 
~ CHF am MM ~ have I ,n~ e=emN te~t abmm~. 
~.  A reduced mu~e m~mt~ ca~¢W may I~m~l peak V O~ a~ ~l  to 
al~om~ mmm~ ve~lal~n. ~ch ~ may o ~  to ~e ab. 
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I 1149-161 l Effect of  Device, medistedTltenzpyon 
SymptomaUc Episodes of  Atrkzl ~ 
C. T i ~ ,  HJ. J. V~-,I~,-~. For l~e Mefmr/m,e~g,=~u~-. Acadenwc 
~ feseamh has shown thai atrial ~l la 'aon (AF) can ~ stmclural 
and elet~ut~y,smk)gz(:aJ c,=,a,-,0es in the atria wt,ch promote the permanence 
ot AF. However. no data ex i les  to wl~ether mten~mtmfl wtlh devme.medmted 
theralw may reveme the changes reduced by AF alx:l thet l~ promole longer 
periods of normal sinus rhythm (NSR). The puq:~e of t t~ sludy was to 
examn~ the frequency of AF mcunerces after ,~plantalmn of the IMetnx 
= m l ~  aln~ def4)nllator (lAD). A total of 51 patzertts (pts) were mlplante¢l 
vv~ a mean f~ow-up of 25~ * ~38 rays. During the s~o'y per i l  of 20 
41 pts sou~t tmatmant fo r~ m- ,e ,~s  AF epis~es (SE), 
mean 6 et~sodes per p~;i~L PIS wifft Mwer ~ 3 SE were e~duded hem the 
analysis. In a~;;o,-,, pts wha e ~  no SE afire an emcdlmy mlenmnlmn 
such as a change m o~g therapy or algal ftuttm ab la l~ were also exdude~L 
For ftte rema~ 21 pls. mean fo~tow-u~ of 231 ± 106 days. ths duretzon 
between ~ were grouped a~o ~ and an average dumUon was 
c~,-,~.,~ fo~ each ¢p~;~. The dmtribution of ff~ese qua~ mmms were 
~re¢ l  u~ng Kal~an-Me~r czn~es. 
Res~.~s: The median quaffffe ~ durations were 7.3.17, 21 ax~l 3S.3 
days f~r the first, se¢on~ ~1 and fourth quarUes respectrve~. The Kaplan- 
Meier curves showed an ~l~reesmg tren¢l m episode ~zration. 
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Conclusion: Preliminary findings from this study suggests that mainte- 
nance of sinus rhythm with an lAD prolongs the interval between symptomatic 
episodes of AF. Further studies are needed to examine this phenomenon 
